Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Somatic mutations in tet methylcytosine dioxygenase 2 (TET2), which encodes an epigenetic modifier enzyme, drive the development of haematopoietic malignancies 1-7. In both humans and mice, TET2 deficiency leads to increased self-renewal of haematopoietic stem cells with a net developmental bias towards the myeloid lineage 1,4,8,9. However, pre-leukaemic myeloproliferation (PMP) occurs in only a fraction of Tet2-/- mice 8,9 and humans with TET2 mutations 1,3,5-7, suggesting that extrinsic non-cell-autonomous factors are required for disease onset. Here we show that bacterial translocation and increased interleukin-6 production, resulting from dysfunction of the small-intestinal barrier, are critical for the development of PMP in mice that lack Tet2 expression in haematopoietic cells. Furthermore, in symptom-free Tet2-/- mice, PMP can be induced by disrupting intestinal barrier integrity, or in response to systemic bacterial stimuli such as the toll-like receptor 2 agonist. PMP was reversed by antibiotic treatment and failed to develop in germ-free Tet2-/- mice, which illustrates the importance of microbial signals in the development of this condition. Our findings demonstrate the requirement for microbial-dependent inflammation in the development of PMP and provide a mechanistic basis for the variation in PMP penetrance observed in Tet2-/- mice. This study will prompt new lines of investigation that may profoundly affect the prevention and management of haematopoietic malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In hematologic malignancies, preclinical evidence suggests a careful balance, where either antibiotics or gut bacterial translocation can trigger leukemic progression in genetically-predisposed hosts (47, 92).”
From The microbiome and human cancer (2021) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cytokines display overlapping features, such as inducing cell cycle entry of HSCs and their differentiation, frequently toward the granulo-monocytic lineage 1,4-6,12-15 .”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anti-IL-6 antibodies reduced the growth of Tet2−/− cells in culture and reduced number of myeloid cells in vivo, although it remains unclear whether such therapy alters their competitive growth advantage [92].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Anti-IL-6 antibodies reduced the growth of Tet2−/− cells in culture and reduced number of myeloid cells in vivo, although it remains unclear whether such therapy alters their competitive growth advantage [92].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [92]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O'Hara, R. B., Solymos, P., Stevens, M. H. H., Szoecs, E., et al. (2001) · CRAN: Contributed Packages · doi:10.32614/cran.package.vegan · Cited by 22,615
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay‐Kumar, M. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1525s104 · Cited by 2,090
Cited by
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
“Yet, another probably underappreciated mechanism is the ability of chemotherapies to cause normal tissue damage, specifically in the intestine, translocation of inflammatory microbial products and activation of systemic inflammation, which can further promote tumors, as demonstrated for myelodysplastic syndrome (Meise…”
BackgroundThe microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“Spontaneous gut bacterial translocation in Tet2 mice also drove preleukemic myeloproliferation (PMP), which leads to leukemia if unchecked, in an IL-6–dependent manner (47).”
BackgroundClonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156
“Recent studies have implicated genetic predispositions (38, 62) as well as the microbiome (63) in the etiology and progression of clonal hematopoiesis.”
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
RetractedCancer therapy shapes the fitness landscape of clonal hematopoiesis
Bolton, K. L., Ptashkin, R. N., Gao, T., Braunstein, L., Devlin, S. M., Kelly, D., Patel, M., Berthon, A., Syed, A., Yabe, M., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00710-0 · Cited by 751
“Our work adds to early evidence 45,46 that external stressors are critical in shaping gene-dependent selection of clonal mosaicism.”
Metadata
- Authors
- Meisel, M., Hinterleitner, R., Pacis, A., Chen, L., Earley, Z. M., Mayassi, T., Pierre, J. F., Ernest, J. D., Galipeau, H. J., Thuille, N., Bouziat, R., Buscarlet, M., Ringus, D. L., Wang, Y., Li, Y., Dinh, V., Kim, S. M., McDonald, B. D., Zurenski, M. A., Musch, M. W., Furtado, G. C., Lira, S. A., Baier, G., Chang, E. B., Eren, A. M., Weber, C. R., Busque, L., Godley, L. A., Verdú, E. F., Barreiro, L. B., & Jabri, B.
- Affiliations
- University of Chicago (US)
- CHU Sainte-Justine Research Center (CA)
- University of Tennessee Health Science Center (US)
- McMaster University (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- Innsbruck Medical University (AT)
- Marine Biological Laboratory (US)
- ORCID
- Meisel, Marlies
- Hinterleitner, Reinhard
- Pacis, Alain
- Earley, Zachary M.
- Mayassi, Toufic
- Pierre, Joseph F.
- Ernest, Jordan D.
- Galipeau, Heather J.
- Bouziat, Romain
- Buscarlet, Manuel
- Wang, Yitang
- Li, Ye
- Kim, Sangman M.
- McDonald, Benjamin D.
- Musch, Mark W.
- Baier, Gottfried
- Chang, Eugene B.
- Eren, A. Murat
- Weber, Christopher R.
- Busque, Lambert
- Godley, Lucy A.
- Barreiro, Luis B.
- Venue
- Nature
- Published
- 2018-05
- Volume
- 557
- Issue
- 7706
- Pages
- 580-584
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6238954
- OpenAlex
- W2803360616
- Cited by
- 406
- References
- 43
- Citations by year
- 2026: 30 · 2025: 47 · 2024: 51 · 2023: 60 · 2022: 67 · 2021: 52 · 2020: 58 · 2019: 34 · 2018: 6
- FWCI
- 26.90
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Chicago
- Crohn's and Colitis Foundation (480735)
- National Institutes of Health
- National Cancer Institute (R01CA161373, P30CA014599)
- National Institute of Allergy and Infectious Diseases (T32AI007090)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK105728, R01DK067180, P01DK072201, P30DK042086, R01DK110352)
- National Institute of Biomedical Imaging and Bioengineering (T32EB009412)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- TET2 deficiency, bacterial translocation, intestinal barrier dysfunction, interleukin-6, microbial signals, TLR2, antibiotic therapy, germ-free mice, hematologic malignancies, inflammation
- MeSH terms
- Animals, Bacterial Infections, DNA-Binding Proteins, Female, Germ-Free Life, Inflammation, Intestinal Mucosa, Lactobacillus, Leukemia, Male, Permeability, Proto-Oncogene Proteins, Interleukin-6, Bacterial Physiological Phenomena, Penetrance, Cell Proliferation, Dioxygenases, Toll-Like Receptor 2, Mice, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. https://app.cochat.ai/papers/10.1038/s41586-018-0125-z
- The paper
- Meisel, M., Hinterleitner, R., Pacis, A., Chen, L., Earley, Z. M., Mayassi, T., Pierre, J. F., Ernest, J. D., Galipeau, H. J., Thuille, N., Bouziat, R., Buscarlet, M., Ringus, D. L., Wang, Y., Li, Y., Dinh, V., Kim, S. M., McDonald, B. D., Zurenski, M. A., . . . Jabri, B. (2018). Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. https://doi.org/10.1038/s41586-018-0125-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.